NCT04850625View on ClinicalTrials.gov

Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine

CompletedOBSERVATIONAL
Enrollment

224

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Breast Cancer
Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT04850625 - Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine | Biotech Hunter | Biotech Hunter